Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 19, 2011

Premium

Regulus Therapeutics said it has named Mary Glanville as its senior vice president of human capital and Christopher Aker as its senior director of legal affairs and secretary.

Glanville will be responsible for employee recruitment and retention, as well as aligning staff with the company's business needs. She joins Regulus from Anadys Pharmaceuticals where she led human resources.

Aker will handle all of Regulus' legal, corporate, and intellectual property matters, the company said. He previously served as corporate counsel and senior director of administration at Phenomix, a now shuttered drug developer.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.